MEDIROM HEALTHCARE TECHNOLOGIES INC

NASDAQ: MRM (MEDIROM Healthcare Technologies)

Last update: 15 Nov, 4:57AM

2.70

0.11 (4.17%)

Previous Close 2.59
Open 2.57
Volume 1,290
Avg. Volume (3M) 689,101
Market Cap 13,603,686
Price / Sales 0.330
Price / Book 13.24
52 Weeks Range
2.27 (-15%) — 8.39 (210%)
Earnings Date 18 Jun 2024
Profit Margin 1.69%
Operating Margin (TTM) -2.27%
Diluted EPS (TTM) -0.160
Quarterly Revenue Growth (YOY) -5.80%
Quarterly Earnings Growth (YOY) 42.30%
Total Debt/Equity (MRQ) 1,689.78%
Current Ratio (MRQ) 0.490
Operating Cash Flow (TTM) -631.74 M
Levered Free Cash Flow (TTM) -1.31 B
Return on Assets (TTM) -3.60%
Return on Equity (TTM) 146.95%

Market Trend

Short Term Medium Term
Industry Personal Services (US) Mixed Bullish
Personal Services (Global) Mixed Bullish
Stock MEDIROM Healthcare Technologies - -

AIStockmoo Score

-0.5
Analyst Consensus 0.0
Insider Activity NA
Price Volatility 0.5
Technical Moving Averages 0.0
Technical Oscillators -2.5
Average -0.50

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
MRM 14 M - - 13.24
EM 173 M 4.51% 22.17 0.500
CLIK 22 M - 25.60 53.57
TRNR 3 M - - 0.480
FTDR 4 B - 18.57 16.30
YYGH 60 M - 43.50 10.40

MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.

Sector Consumer Cyclical
Industry Personal Services
% Held by Insiders 40.37%

No data within this time range.

No data within this time range.

Date Type Details
13 Dec 2024 Announcement MEDIROM Healthcare Technology‘s Subsidiary, MEDIROM MOTHER Labs, Raises an Aggregate Total of JPY260.3 Million in its Series A Financing Round
11 Dec 2024 Announcement Two Senior MEDIROM Mother Labs Executives Invest in Mother Labs’ Series A Financing at a Pre-Money Valuation of JPY9 Billion (as of December 1, 2024, approximately USD $59,000,000)
11 Dec 2024 Announcement MEDIROM Healthcare Technologies Inc. Announces Closing of Public Offering
09 Dec 2024 Announcement MEDIROM Healthcare Technologies Has Received Orders for Over 25,000 MOTHER Bracelet Units
09 Dec 2024 Announcement MEDIROM Healthcare Technologies Inc. Announces Pricing of Public Offering
06 Dec 2024 Announcement M3 Group Joins MEDIROM Mother Labs’ Series A Financing Round at JPY9 Billion (as of December 1, 2024, approximately USD $59,000,000) Pre-Money Valuation
02 Dec 2024 Announcement M3 Group Joins MEDIROM Mother Labs’ Series A Financing Round at JPY9 Billion (as of December 1, 2024, approximately USD $59,000,000) Pre-Money Valuation
07 Nov 2024 Announcement Healthy and Beauty Synergies: MEDIROM Healthcare Technologies and SBC Medical Group Holdings Announce Business Alliance
07 Nov 2024 Announcement SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance
23 Oct 2024 Announcement Lead Real Estate Co., LTD Introduces Fitness Tracker “MOTHER Bracelet®︎” to ENT TERRACE and Invites Activities that Lead to Social Support
15 Oct 2024 Announcement Elematec Corporation Forms a Business Alliance with and Agrees to Make a Strategic Investment in MEDIROM Healthcare Technologies’ MOTHER Labs Subsidiary
08 Oct 2024 Announcement Lead Real Estate Co., LTD Announces Business Alliance with MEDIROM Healthcare Technologies Inc. for Healthtech Support in the Hotel Business
07 Oct 2024 Announcement MEDIROM Rehab Solutions Inc. Acquires Rehabilitation Centers from Y’s, Inc.
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2024 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria